Weekly prescription treatments that support appetite regulation and sustainable weight loss—paired with clinical oversight as your body changes.
Prescribed online·Licensed U.S. pharmacy·No charge unless approved
Treatments
Choose the option you want to explore.
Both are once-weekly injections with gradual dose adjustments. Select either treatment below to see its pathway, approach, and monthly price in one place.
Dual pathway
Tirzepatide
Tirzepatide is a once-weekly injectable medication formulation that targets both GLP-1 and GIP receptors to support blood sugar regulation, enhance insulin sensitivity, and promote weight loss.
It helps reduce appetite, slow gastric emptying, and improve metabolic flexibility, making it one of the most effective tools for long-term fat loss and metabolic health support.
GLP-1 + GIPWeekly injection$349/month
The key difference: two hormone pathways and a higher monthly price.
Semaglutide is a GLP-1 receptor agonist that supports appetite regulation, blood sugar balance, and sustainable weight management.
By slowing gastric emptying and increasing feelings of fullness, it helps reduce caloric intake naturally, supporting steady, long-term progress toward metabolic health goals when combined with lifestyle changes.
GLP-1Weekly injection$259/month
The key difference: one hormone pathway and a lower monthly price.
Yes. You select Tirzepatide or Semaglutide. A licensed provider then reviews your intake and determines whether that prescription is safe and appropriate.
What is the main difference?
Tirzepatide acts on GLP-1 and GIP pathways. Semaglutide acts on the GLP-1 pathway. Both are weekly injections used alongside diet and exercise.